
Help accelerate research for
Scleroderma
See if you qualify to participate in this at-home research study today. Your contribution could help find new treatments.
By clicking continue, you agree to our privacy policy and terms and conditions consent to answer screening questions for potential enrollment in an active research study.
By clicking continue, you agree to our privacy policy and terms and conditions consent to answer screening questions for potential enrollment in an active research study.
Study Name:
Prospective Longitudinal Collection of Whole Blood and Patient Reported Outcomes from Subjects Diagnosed with Various Inflammatory Conditions
This study is for people with:
Scleroderma
Number of participants:
30 participants
Sponsored By:
Sanguine Biosciences
Compensation Up To:
$580
Purpose:
The main purpose of this study is to collect whole blood and patient-reported outcome (PRO) measures from individuals diagnosed with Scleroderma. Blood samples and completed questionnaires will be provided to researchers to study trends in biomarkers and patient's quality of life during potential relapsing episodes or flares for Scleroderma. Your blood and your disease perceptions may assist researchers in developing a new treatment for Scleroderma.
Study Design:
3-4 At-Home Visits ($100 each completed visit) & 6 online questionnaires ($30 each completed questionnaire)
You may qualify if you:
- Are 18 years of age or older
- Have been diagnosed with Scleroderma
- Live in United States
You may not qualify if you:
- Are pregnant
- Have a known history of HIV, hepatitis or other infectious diseases
- Experienced excess blood loss including blood donation defined as 250 mL in the last month or 500 mL in the last two months
Participate from home!
United States
How it Works
It’s a simple, three-step process.

Submit a health profile by answering basic questions about your medical history.

Speak with a research coordinator to learn more about what is required to participate.

Complete study requirements from home with the help of our mobile health staff.
Who We Are
We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research from home. Our goal is to develop mobile technologies that empower patients to participate in research for conditions that matter most to them, regardless of their location or ability to travel.
We work directly with patients and advocacy groups to accelerate research through convenience and transparency while guiding each patient every step of the way.
Sanguine's Expertise in Accelerating Research

our community

member has participated

completed by Sanguine
